Medicare Enrolled

Dr. Helen Patzanakidis, M.D.

Internal Medicine · Corona, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
854 MAGNOLIA AVE STE 101, Corona, CA 92879
9517513150
In practice since 2006 (19 years)
NPI: 1639288368 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patzanakidis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patzanakidis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patzanakidis

Dr. Helen Patzanakidis is an internal medicine specialist in Corona, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Patzanakidis performed 985 Medicare services across 663 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patzanakidis received a total of $5,731 from 44 pharmaceutical and/or device companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patzanakidis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 32% volume in CA $5,731 industry payments

Medicare Practice Summary

Medicare Utilization ↗
985
Medicare services
Top 32% in CA for internal medicine
663
Unique beneficiaries
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~52 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
420 $60 $184
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
160 $85 $261
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
129 $133 $263
Annual alcohol misuse screening, 5 to 15 minutes 72 $16 $16
Annual depression screening 68 $19 $37
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
35 $10 $30
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
27 $2 $5
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
23 $10 $29
Transitional care management, high complexity
Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem.
21 $228 $509
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $39 $116
Annual wellness visit, initial visit
A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment.
11 $170 $334
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,731
Total received (2018-2024)
Avg $819/year across 7 years
Top 15% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
310
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,731 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$932
2023
$707
2022
$668
2021
$926
2020
$581
2019
$902
2018
$1,015

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$93
Abbott Laboratories
$87
Novo Nordisk Inc
$84
Lilly USA, LLC
$73
GlaxoSmithKline, LLC.
$60
Astellas Pharma US Inc
$58
Amgen Inc.
$57
PFIZER INC.
$50
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$40
SANOFI-AVENTIS U.S. LLC
$39
Bayer Healthcare Pharmaceuticals Inc.
$36
Otsuka America Pharmaceutical, Inc.
$29
SI-BONE, INC.
$25
ABBVIE INC.
$22
Phathom Pharmaceuticals, Inc.
$18
Top 3 companies account for 36.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$778
Novo Nordisk Inc
$761
Merck Sharp & Dohme Corporation
$472
AbbVie Inc.
$335
GlaxoSmithKline, LLC.
$313
Lilly USA, LLC
$302
Astellas Pharma US Inc
$295
Abbott Laboratories
$248
Boehringer Ingelheim Pharmaceuticals, Inc.
$243
SANOFI-AVENTIS U.S. LLC
$232
PFIZER INC.
$210
Amgen Inc.
$173
Novartis Pharmaceuticals Corporation
$132
Eisai Inc.
$104
Biohaven Pharmaceuticals, Inc.
$91
ABBVIE INC.
$68
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$65
E.R. Squibb & Sons, L.L.C.
$62
Allergan Inc.
$59
Biohaven Pharmaceutical Holding Company Ltd.
$57
Teva Pharmaceuticals USA, Inc.
$54
SI-BONE, INC.
$50
Dexcom, Inc.
$50
Allergan, Inc.
$48
Merck Sharp & Dohme LLC
$47
Edwards Lifesciences Corporation
$43
Phadia US Inc.
$40
Janssen Pharmaceuticals, Inc
$38
Bayer Healthcare Pharmaceuticals Inc.
$36
Noden Pharma USA Inc
$32
CVRx, Inc.
$32
Circassia Pharmaceuticals Inc
$29
Otsuka America Pharmaceutical, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$26
Medtronic, Inc.
$22
Hologic Sales and Service, LLC
$21
Bausch Health US, LLC
$18
Phathom Pharmaceuticals, Inc.
$18
Amarin Pharma Inc.
$18
Ferring Pharmaceuticals Inc.
$17
AbbVie, Inc.
$16
Hologic, LLC
$16
Sunovion Pharmaceuticals Inc.
$16
Biogen, Inc.
$11
Top 3 companies account for 35.1% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ANORO · APLENZIN · APTIMA · Aimovig · BELSOMRA · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · Barostim Neo System · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CREON · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · Dayvigo · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · EMGALITY · ENTRESTO · EUFLEXXA · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL 9 · GEMTESA · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · MAZOR X SYSTEM · MOUNJARO · MYRBETRIQ · Myrbetriq · NUEDEXTA · NURTEC ODT · Otezla · Ozempic · PNEUMOVAX 23 · PREMARIN · ROTATEQ · RYBELSUS · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPINRAZA · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TEKTURNA · THINPREP 2000 PROCESSOR · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · TZIELD · Tresiba · UBRELVY · VESICARE · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an internal medicine specialist in Corona?
Compare internal medicine physicians in the Corona area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
2,083
Per 100K population
85.0
County median income
$89,672
Nearest hospital
KAISER FOUNDATION HOSPITAL, RIVERSIDE
3.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patzanakidis is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 15% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Patzanakidis experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Patzanakidis performed 420 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patzanakidis receive payments from pharmaceutical companies?
Yes. Dr. Patzanakidis received a total of $5,731 from 44 companies across 310 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patzanakidis's costs compare to other internal medicine physicians in Corona?
Dr. Patzanakidis's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patzanakidis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →